Maria Vittoria Dieci (M Vittoria Dieci)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 40

Top Venues

NPJ breast cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancers

British journal of cancer

Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Oncologico Veneto Istituto di Ricovero e Cura a Carattere Scientifico

Italy

Consultant Physycian :: Medical Oncology 2

University of Padua Feb 01 2019

Italy

Assistant professor (Ricercatore tempo determinato tipo B)

University of Padua Feb 01 2016 - Jan 31 2019

Italy

Researcher (Ricercatore tempo determinato tipo A)

Publications

Maria Vittoria Dieci, Valentina Guarneri
Gaining ground in personalized breast cancer therapy: lesson learned from PHERGain. Nature reviews. Clinical oncology (2024)
Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Gene-expression assays to tailor adjuvant endocrine therapy for HR+/HER2- breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Iros Barozzi, Neil Slaven, Eleonora Canale, Rui Lopes, Inês A M Barbosa, Melusine Bleu, Diana Ivanoiu, Claudia Pacini, Emanuela Mensa, Alfie Chambers, Sara Bravaccini, Sara Ravaioli, Gyorffy Balazs, Maria Vittoria Dieci, Giancarlo Pruneri, Giorgio Giacomo Galli, Luca Magnani
A functional survey of the regulatory landscape of estrogen-receptor-positive breast cancer evolution. Cancer discovery (2024)
Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Maria Vittoria Dieci, Valentina Guarneri
Gaining ground in personalized breast cancer therapy: lesson learned from PHERGain. Nature reviews. Clinical oncology 21 (9) (2024)
Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Michele Bottosso, Federica Miglietta, Grazia Maria Vernaci, Tommaso Giarratano, Maria Vittoria Dieci, Valentina Guarneri, Gaia Griguolo
Gene Expression Assays to Tailor Adjuvant Endocrine Therapy for HR+/HER2- Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Grazia Maria Vernaci, Edoardo Vincenzo Savarino, Ilaria Patuzzi, Sonia Facchin, Fabiana Zingone, Davide Massa, Giovanni Faggioni, Tommaso Giarratano, Federica Miglietta, Gaia Griguolo, Angelo Paolo Dei Tos, Marcello Lo Mele, Elisa Gasparini, Giancarlo Bisagni, Valentina Guarneri, Maria Vittoria Dieci
Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy. The oncologist (2023)
Fara Brasó-Maristany, Gaia Griguolo, Nuria Chic, Tomás Pascual, Laia Paré, Julia Maues, Patricia Galván, Maria Vittoria Dieci, Federica Miglietta, Tommaso Giarratano, Olga Martínez-Sáez, Mercedes Marín-Aguilera, Francesco Schettini, Benedetta Conte, Laura Angelats, Maria Vidal, Barbara Adamo, Montserrat Muñoz, Esther Sanfeliu, Blanca González, Ana Vivancos, Patricia Villagrasa, Joel S Parker, Charles M Perou, PierFranco Conte, Aleix Prat, Valentina Guarneri
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1. Journal of the National Cancer Institute 115 (3) (2023)
Maria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini, Antonio Frassoldati, Roberto Vicini, Sara Balduzzi, Roberto D'amico, Pierfranco Conte, Valentina Guarneri
Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial. NPJ breast cancer 9 (1) (2023)
Federica Miglietta, Moira Ragazzi, Bethania Fernades, Gaia Griguolo, Davide Massa, Fabio Girardi, Michele Bottosso, Alessandra Bisagni, Giovanni Zarrilli, Francesca Porra, Daniela Iannaccone, Leocadia Dore, Mariangela Gaudio, Giacomo Santandrea, Angelo Paolo Dei Tos, Marcello Lo Mele, Rita De Sanctis, Alberto Zambelli, Giancarlo Bisagni, Valentina Guarneri, Maria Vittoria Dieci
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Fara Brasó-Maristany, Gaia Griguolo, Nuria Chic, Tomás Pascual, Laia Paré, Julia Maues, Patricia Galván, Maria Vittoria Dieci, Federica Miglietta, Tommaso Giarratano, Olga Martínez-Sáez, Mercedes Marín-Aguilera, Francesco Schettini, Benedetta Conte, Laura Angelats, Maria Vidal, Barbara Adamo, Montserrat Muñoz, Esther Sanfeliu, Blanca González, Ana Vivancos, Patricia Villagrasa, Joel S Parker, Charles M Perou, PierFranco Conte, Aleix Prat, Valentina Guarneri
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1. Journal of the National Cancer Institute 115 (3) (2023)
Federica Miglietta, Maria Vittoria Dieci
How can we refine the prognostic stratification of triple-negative breast cancer? Expert review of anticancer therapy (2023)
Maria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini, Antonio Frassoldati, Roberto Vicini, Sara Balduzzi, Roberto D'amico, Pierfranco Conte, Valentina Guarneri
Author Correction: Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial. NPJ breast cancer 9 (1) (2023)
Fara Brasó-Maristany, Gaia Griguolo, Nuria Chic, Tomás Pascual, Laia Paré, Julia Maues, Patricia Galván, Maria Vittoria Dieci, Federica Miglietta, Tommaso Giarratano, Olga Martínez-Sáez, Mercedes Marín-Aguilera, Francesco Schettini, Benedetta Conte, Laura Angelats, Maria Vidal, Barbara Adamo, Montserrat Muñoz, Esther Sanfeliu, Blanca González, Ana Vivancos, Patricia Villagrasa, Joel S Parker, Charles M Perou, PierFranco Conte, Aleix Prat, Valentina Guarneri
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1. Journal of the National Cancer Institute 115 (3) (2023)
Maria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini, Antonio Frassoldati, Roberto Vicini, Sara Balduzzi, Roberto D'amico, Pierfranco Conte, Valentina Guarneri
Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial. NPJ breast cancer 9 (1) (2023)
Maria Vittoria Dieci, Giancarlo Bisagni, Stefania Bartolini, Antonio Frassoldati, Roberto Vicini, Sara Balduzzi, Roberto D'amico, Pierfranco Conte, Valentina Guarneri
Type of adjuvant endocrine therapy and disease-free survival in patients with early HR-positive/HER2-positive BC: analysis from the phase III randomized ShortHER trial. NPJ breast cancer 9 (1) (2023)
Michele Bottosso, Gaia Griguolo, Léa Sinoquet, Maria Cristina Guarascio, Vittoria Aldegheri, Federica Miglietta, Grazia Vernaci, Caterina Barbieri, Fabio Girardi, William Jacot, Valentina Guarneri, Amélie Darlix, Maria Vittoria Dieci
Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases. British journal of cancer (2023)
PierFranco Conte, Giancarlo Bisagni, Federico Piacentini, Samanta Sarti, Santino Minichillo, Elisa Anselmi, Michele Aieta, Vittorio Gebbia, Alessio Schirone, Antonino Musolino, Ornella Garrone, Alessandra Beano, Anita Rimanti, Francesco Giotta, Anna Turletti, Federica Miglietta, Maria Vittoria Dieci, Roberto Vicini, Sara Balduzzi, Roberto D'Amico, Valentina Guarneri
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Maria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, Fabio Canino, Carlo Alberto Giorgi, Enrico Cumerlato, Ottavia Amato, Davide Massa, Gaia Griguolo, Elisa Genovesi, Giovanna Garufi, Diana Giannarelli, Antonio Tornincasa, Lucia Trudu, Silvia Michieletto, Tania Saibene, Marcello Lo Mele, Matteo Fassan, Giovanni Zarrilli, Federico Piacentini, Emilio Bria, Valentina Guarneri
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation. British journal of cancer (2022)
Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Angelo Paolo Dei Tos, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Maria Vernaci, Ottavia Amato, Francesca Porra, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment. NPJ breast cancer 8 (1) (2022)
Davide Massa, Anna Tosi, Antonio Rosato, Valentina Guarneri, Maria Vittoria Dieci
Multiplexed In Situ Spatial Protein Profiling in the Pursuit of Precision Immuno-Oncology for Patients with Breast Cancer. Cancers 14 (19) (2022)
Maria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, Fabio Canino, Carlo Alberto Giorgi, Enrico Cumerlato, Ottavia Amato, Davide Massa, Gaia Griguolo, Elisa Genovesi, Giovanna Garufi, Diana Giannarelli, Antonio Tornincasa, Lucia Trudu, Silvia Michieletto, Tania Saibene, Marcello Lo Mele, Matteo Fassan, Giovanni Zarrilli, Federico Piacentini, Emilio Bria, Valentina Guarneri
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation. British journal of cancer (2022)
Maria Vittoria Dieci, Gaia Griguolo, Michele Bottosso, Vassilena Tsvetkova, Carlo Alberto Giorgi, Grazia Maria Vernaci, Silvia Michieletto, Silvia Angelini, Alberto Marchet, Giulia Tasca, Elisa Genovesi, Enrico Cumerlato, Marcello Lo Mele, PierFranco Conte, Valentina Guarneri
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy. NPJ breast cancer 7 (1) (2021)
Tomás Pascual, Aranzazu Fernandez-Martinez, Maki Tanioka, Maria Vittoria Dieci, Sonia Pernas, Joaquin Gavila, Valentina Guarnieri, Javier Cortes, Patricia Villagrasa, Núria Chic, María Jesús Vidal Losada, Barbara Adamo, Montserrat Muñoz, Gaia Griguolo, Antonio Llombart, PierFranco Conte, Mafalda Oliveira, Benedetta Conte, Laia Paré, Patricia Galvan, Lisa Anne Carey, Charles M Perou, Aleix Prat
Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (11) (2021)
Maria Vittoria Dieci, Valentina Guarneri, Anna Tosi, Giancarlo Bisagni, Antonino Musolino, Simon Spazzapan, Gabriella Moretti, Grazia Maria Vernaci, Gaia Griguolo, Tommaso Giarratano, Loredana Urso, Francesca Schiavi, Claudia Pinato, Giovanna Magni, Marcello Lo Mele, Gian Luca De Salvo, Antonio Rosato, PierFranco Conte
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Angelo Paolo Dei Tos, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Maria Vernaci, Ottavia Amato, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
Evolution of HER2-low expression from primary to recurrent breast cancer. NPJ breast cancer 7 (1) (2021)
Federica Miglietta, Gaia Griguolo, Michele Bottosso, Tommaso Giarratano, Marcello Lo Mele, Angelo Paolo Dei Tos, Matilde Cacciatore, Elisa Genovesi, Debora De Bartolo, Grazia Maria Vernaci, Ottavia Amato, PierFranco Conte, Valentina Guarneri, Maria Vittoria Dieci
Author Correction: Evolution of HER2-low expression from primary to recurrent breast cancer. NPJ breast cancer 7 (1) (2021)
Maria Vittoria Dieci, Federica Miglietta, Valentina Guarneri
Immune Infiltrates in Breast Cancer: Recent Updates and Clinical Implications. Cells 10 (2) (2021)
Matteo Lambertini, Marcello Ceppi, Anne Sophie Hamy, Olivier Caron, Philip D Poorvu, Estela Carrasco, Albert Grinshpun, Kevin Punie, Christine Rousset-Jablonski, Alberta Ferrari, Shani Paluch-Shimon, Angela Toss, Claire Senechal, Fabio Puglisi, Katarzyna Pogoda, Jose Alejandro Pérez-Fidalgo, Laura De Marchis, Riccardo Ponzone, Luca Livraghi, Maria Del Pilar Estevez Diz, Cynthia Villarreal Garza, Maria Vittoria Dieci, Florian Clatot, Fran Ois P Duhoux, Rossella Graffeo, Luis Teixeira, Octavi Córdoba, Amir Sonnenblick, Arlindo R Ferreira, Ann H Partridge, Antonio Di Meglio, Claire Saule, Fedro Alessandro Peccatori, Marco Bruzzone, Marie Daphne t'Kint de Roodenbeke, Lieveke Ameye, Judith Balmaña, Lucia Del Mastro, Hatem A Azim
Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants. NPJ breast cancer 7 (1) (2021)
Gaia Griguolo, Maria Vittoria Dieci, Laia Paré, Federica Miglietta, Daniele Giulio Generali, Antonio Frassoldati, Luigi Cavanna, Giancarlo Bisagni, Francesco Giotta, Enrico Tagliafico, Katia Cagossi, Guido Ficarra, Aleix Prat, Pierfranco Conte, Valentina Guarneri
Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer. NPJ breast cancer 7 (1) (2021)
Giovanni Zarrilli, Gianluca Businello, Maria Vittoria Dieci, Silvia Paccagnella, Valentina Carraro, Rocco Cappellesso, Federica Miglietta, Gaia Griguolo, Valentina Guarneri, Marcello Lo Mele, Angelo Paolo Dei Tos
The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies. International journal of molecular sciences 21 (21) (2020)
Gaia Griguolo, Fara Brasó-Maristany, Blanca González-Farré, Tomás Pascual, Núria Chic, Tamara Saurí, Ronald Kates, Oleg Gluz, Débora Martínez, Laia Paré, Vassilena Tsvetkova, David Pesantez, Maria Vidal, Barbara Adamo, Montserrat Muñoz, Patricia Galván, Laura Barberá, Miriam Cuatrecasas, Mathias Christgen, Hans Kreipe, Inés Monge-Escartín, Patricia Villagrasa, Dolors Soy, Tommaso Giarratano, Maria Vittoria Dieci, PierFranco Conte, Nadia Harbeck, Valentina Guarneri, Aleix Prat
ERBB2 mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer. Cancers 12 (7) (2020)
Valentina Guarneri, Maria Vittoria Dieci, Giancarlo Bisagni, Alba A Brandes, Antonio Frassoldati, Luigi Cavanna, Antonino Musolino, Francesco Giotta, Anita Rimanti, Ornella Garrone, Elena Bertone, Katia Cagossi, Oriana Nanni, Enrico Orvieto, Gaia Griguolo, Matteo Curtarello, Loredana Urso, Laia Paré, Nuria Chic, Roberto D'Amico, Aleix Prat, PierFranco Conte
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (22) (2020)
Federica Miglietta, Maria Silvia Cona, Maria Vittoria Dieci, Valentina Guarneri, Nicla La Verde
An overview of immune checkpoint inhibitors in breast cancer. Exploration of targeted anti-tumor therapy 1 (6) (2020)
Maria Vittoria Dieci, Lucia Del Mastro, Michela Cinquini, Filippo Montemurro, Laura Biganzoli, Laura Cortesi, Alberto Zambelli, Carmen Criscitiello, Alessia Levaggi, Benedetta Conte, Massimo Calabrese, Alba Fiorentino, Caterina Marchio, Corrado Tinterri, Veronica Andrea Fittipaldo, Giovanni Pappagallo, Stefania Gori
Inclusion of Platinum Agents in Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer Patients: Development of GRADE (Grades of Recommendation, Assessment, Development and Evaluation) Recommendation by the Italian Association of Medical Oncology (AIOM). Cancers 11 (8) (2019)
Luisa Carbognin, Federica Miglietta, Ida Paris, Maria Vittoria Dieci
Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives. Cancers 11 (9) (2019)
Maria Vittoria Dieci, Vassilena Tsvetkova, Enrico Orvieto, Federico Piacentini, Guido Ficarra, Gaia Griguolo, Federica Miglietta, Tommaso Giarratano, Claudia Omarini, Serena Bonaguro, Rocco Cappellesso, Camillo Aliberti, Grazia Vernaci, Carlo Alberto Giorgi, Giovanni Faggioni, Giulia Tasca, Pierfranco Conte, Valentina Guarneri
Immune characterization of breast cancer metastases: prognostic implications. Breast cancer research : BCR 20 (1) (2018)
Gaia Griguolo, Maria Vittoria Dieci, Tommaso Giarratano, Carlo Alberto Giorgi, Enrico Orvieto, Cristina Ghiotto, Franco Berti, Alessandro Della Puppa, Cristina Falci, Eleonora Mioranza, Giulia Tasca, Nicola Milite, Federica Miglietta, Renato Scienza, Pierfranco Conte, Valentina Guarneri
Beyond breast specific-Graded Prognostic Assessment in patients with brain metastases from breast cancer: treatment impact on outcome. Journal of neuro-oncology 131 (2) (2016)
Celine Lefebvre, Thomas Bachelot, Thomas Filleron, Marion Pedrero, Mario Campone, Jean-Charles Soria, Christophe Massard, Christelle Lévy, Monica Arnedos, Magali Lacroix-Triki, Julie Garrabey, Yannick Boursin, Marc Deloger, Yu Fu, Frédéric Commo, Véronique Scott, Ludovic Lacroix, Maria Vittoria Dieci, Maud Kamal, Véronique Diéras, Anthony Gonçalves, Jean-Marc Ferrerro, Gilles Romieu, Laurence Vanlemmens, Marie-Ange Mouret Reynier, Jean-Christophe Théry, Fanny Le Du, Séverine Guiu, Florence Dalenc, Gilles Clapisson, Hervé Bonnefoi, Marta Jimenez, Christophe Le Tourneau, Fabrice André
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis. PLoS medicine 13 (12) (2016)

Maria Vittoria Dieci.css-eqlu8i{font-size:small;padding-left:4px;} (M Vittoria Dieci)

Publication Activity (10 Years)

Top Topics

Top Venues

Maria Vittoria Dieci (M Vittoria Dieci)